Antiseptic Vaginal Preparation for Reducing Infection Morbidity at Caesarean Section: A Randomized Control Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202411605053903

Enrollment

225

Registered

2024-11-25

Start date

2023-07-31

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Post-Caesarean Puerperal Infection

Interventions

povidone iodine group

chlorhexidine group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women undergoing Caesarean Section at LAUTECH Teaching Hospital who consented to the study

Exclusion criteria

Exclusion criteria: • Patients not consenting • Patients with known allergy/hypersensitivity to chlorhexidine or povidone-iodine • Women with active herpes simplex virus infection • Patient with gynaetresia, • Immunocompromised patients e.g. patients with HIV, Diabetes Mellitus, Malnourished Patients, and Patients on long-term steroid therapy

Design outcomes

Primary

Measure	Time frame
REDUCTION IN THE POST-CAESAREAN INFECTION MORBIDITY i.e PUERPERAL SEPSIS, SURGICAL SITE INFECTION	—

Secondary

Measure	Time frame
MATERNAL AND FETAL COMPLICATION	—

Countries

Nigeria

Contacts

Public ContactADEWALE ADEYEMI

PROFESSOR OF OBSTETRICS AND GYNAECOLOGY

waleadeyemi2004@gmail.com+2348033192130

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026